316 related articles for article (PubMed ID: 18194823)
1. Leflunomide as adjuvant treatment of dermatomyositis.
Boswell JS; Costner MI
J Am Acad Dermatol; 2008 Mar; 58(3):403-6. PubMed ID: 18194823
[TBL] [Abstract][Full Text] [Related]
2. Amyopathic dermatomyositis--an uncommon presentation of dermatomyositis.
Arnson Y; Dovrish Z; Hadari R; Amital H
Isr Med Assoc J; 2007 Jun; 9(6):492-3. PubMed ID: 17642406
[No Abstract] [Full Text] [Related]
3. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
[TBL] [Abstract][Full Text] [Related]
4. Leflunomide-associated pancytopenia with or without methotrexate.
Chan J; Sanders DC; Du L; Pillans PI
Ann Pharmacother; 2004; 38(7-8):1206-11. PubMed ID: 15187208
[TBL] [Abstract][Full Text] [Related]
5. Dysphonia and dermatomyositis: an unusual manifestation.
Wood MW; McNeill E; Mims JW; Wright SC
Laryngoscope; 2013 Feb; 123(2):460-2. PubMed ID: 23042610
[TBL] [Abstract][Full Text] [Related]
6. Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis.
Sangle VS; Sangle SR; D'Cruz DP
Ann Rheum Dis; 2008 May; 67(5):723. PubMed ID: 18408111
[No Abstract] [Full Text] [Related]
7. Early-stage testicular cancer: a rare association with dermatomyositis.
Tan E; Young D; McLaren B; Wright A
Australas J Dermatol; 2010 May; 51(2):139-41. PubMed ID: 20546223
[TBL] [Abstract][Full Text] [Related]
8. [Methotrexate combined with leflunomide or hydroxychloroquine in the treatment of rheumatoid arteritis].
Zhang X; Cui Y; Luo rQ; Yao RY; Zhou H
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1038-40. PubMed ID: 15312543
[No Abstract] [Full Text] [Related]
9. Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatment.
Cutolo M; Villaggio B; Pizzorni C; Paolino S; Moretti S; Gallo F; Bonassi S; Sulli A; Seriolo B; Montagna P; Soldano S
Ann N Y Acad Sci; 2010 Apr; 1193():15-21. PubMed ID: 20398002
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity.
de Souza RC; de Souza FHC; Miossi R; Shinjo SK
Clin Exp Rheumatol; 2017; 35(6):1011-1013. PubMed ID: 28422003
[TBL] [Abstract][Full Text] [Related]
11. Dermatomyositis with inclusion body myositis pathology.
Layzer R; Lee HS; Iverson D; Margeta M
Muscle Nerve; 2009 Sep; 40(3):469-71. PubMed ID: 19623629
[TBL] [Abstract][Full Text] [Related]
12. Leflunomide-induced toxic epidermal necrolysis.
Teraki Y; Hitomi K; Sato Y; Hamamatsu Y; Izaki S
Int J Dermatol; 2006 Nov; 45(11):1370-1. PubMed ID: 17076730
[No Abstract] [Full Text] [Related]
13. Nodular cystic fat necrosis with calcification in a patient with juvenile dermatomyositis.
Ferenczi K; Berke A; Makkar HS
Pediatr Dermatol; 2014; 31(5):588-90. PubMed ID: 24930439
[TBL] [Abstract][Full Text] [Related]
14. Leflunomide induced acute interstitial pneumonia.
Takeishi M; Akiyama Y; Akiba H; Adachi D; Hirano M; Mimura T
J Rheumatol; 2005 Jun; 32(6):1160-3. PubMed ID: 15940779
[TBL] [Abstract][Full Text] [Related]
15. [Panniculitis in patient undergoing treatment for dermatomyositis with methotrexate].
Feki NB; Khanfir MS; Ghorbel IB; Said F; Houman MH
Pan Afr Med J; 2016; 23():149. PubMed ID: 27279974
[TBL] [Abstract][Full Text] [Related]
16. Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
Ang GC; Werth VP
Arch Dermatol; 2005 Jul; 141(7):855-9. PubMed ID: 16027300
[TBL] [Abstract][Full Text] [Related]
17. Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy.
Lou T; Wang C; Chen Z; Shi C; Tang H; Liu X; Yin P; Yu X
Nephrology (Carlton); 2006 Apr; 11(2):113-6. PubMed ID: 16669971
[TBL] [Abstract][Full Text] [Related]
18. Dermatomyositis and Graves' disease.
Selva-O'Callaghan A; Mijares-Boeckh-Behrens T; Solans-Laque R; Molins-Vara T; Olivé G; Vilardell-Tarrés M
Clin Exp Rheumatol; 2001; 19(5):595-6. PubMed ID: 11579725
[No Abstract] [Full Text] [Related]
19. Treatment of early and refractory dermatomyositis with infliximab: a report of two cases.
Dold S; Justiniano ME; Marquez J; Espinoza LR
Clin Rheumatol; 2007 Jul; 26(7):1186-8. PubMed ID: 16736125
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin for refractory cutaneous dermatomyositis: a retrospective analysis from an academic medical center.
Femia AN; Eastham AB; Lam C; Merola JF; Qureshi AA; Vleugels RA
J Am Acad Dermatol; 2013 Oct; 69(4):654-7. PubMed ID: 24034377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
